Peter C. Farrell

CIK: 0001186102

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)19 (65.5%)

Position reduction

Option Exercises (M)1 (3.4%)

Derivative conversions

Awards (A)6 (20.7%)

Compensation grants

Other (G, F, J, C, D, …)3 (10.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

RMD

RESMED INC

Director

ARCT

Arcturus Therapeutics Holdings Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (29 total)

RMD
RESMED INC
Sep 2, 2026
Sale(S)
Direct
970 shares at avg. $234.73$228K
RMD
RESMED INC
Aug 5, 2026
Sale(S)
Direct
8K shares at avg. $225.00$1.8M
ARCT
Arcturus Therapeutics Holdings Inc.
Jun 5, 2026
Award(A)
Stock option (right to buy)
Direct
15K shares-
RMD
RESMED INC
Apr 1, 2026
Sale(S)
Direct
2K shares at avg. $225.00$450K
RMD
RESMED INC
Mar 4, 2026
Sale(S)
Direct
2K shares at avg. $260.22$520K
RMD
RESMED INC
Feb 4, 2026
Sale(S)
Direct
2K shares at avg. $251.31$503K
RMD
RESMED INC
Jan 7, 2026
Sale(S)
Direct
2K shares at avg. $248.83$498K
RMD
RESMED INC
Dec 3, 2025
Sale(S)
Direct
2K shares at avg. $251.47$503K
RMD
RESMED INC
Nov 24, 2025
Award(A)
ResMed Common Stock Options
Direct
1.3K shares at avg. $250.52-
RMD
RESMED INC
Nov 20, 2025
Award(A)
Direct
536 shares-
RMD
RESMED INC
Nov 14, 2025
Exercise(M)
Direct
11.4K shares at avg. $101.64$1.2M
RMD
RESMED INC
Nov 14, 2025
Tax Payment(F)
Direct
7.3K shares at avg. $244.46$1.8M
RMD
RESMED INC
Nov 12, 2025
Sale(S)
Direct
2K shares at avg. $252.05$504K
RMD
RESMED INC
Nov 11, 2025
Tax Payment(F)
Direct
163 shares at avg. $250.10$41K
RMD
RESMED INC
Jul 2, 2025
Sale(S)
Direct
945 shares at avg. $255.49$241K
ARCT
Arcturus Therapeutics Holdings Inc.
Jun 9, 2025
Award(A)
Stock option (right to buy)
Direct
15K shares-
RMD
RESMED INC
Jun 4, 2025
Sale(S)
Direct
2K shares at avg. $247.32$495K
RMD
RESMED INC
May 7, 2025
Sale(S)
Direct
2K shares at avg. $242.25$485K
RMD
RESMED INC
Apr 2, 2025
Sale(S)
Direct
2K shares at avg. $219.74$439K
RMD
RESMED INC
Mar 5, 2025
Sale(S)
Direct
2K shares at avg. $227.71$455K
RMD
RESMED INC
Feb 5, 2025
Sale(S)
Direct
2K shares at avg. $242.11$484K
RMD
RESMED INC
Jan 2, 2025
Sale(S)
Direct
2K shares at avg. $230.99$462K
RMD
RESMED INC
Dec 4, 2024
Sale(S)
Direct
2K shares at avg. $245.65$491K
RMD
RESMED INC
Nov 25, 2024
Award(A)
ResMed Common Stock Options
Direct
1.5K shares at avg. $249.56-
RMD
RESMED INC
Nov 20, 2024
Award(A)
Direct
542 shares-

		Type	Shares	Price		Ownership
Sep 2, 2026	RMD RESMED INC	Sale(S)	970	$234.73	$227,688	Direct
Aug 5, 2026	RMD RESMED INC	Sale(S)	8,000	$225.00	$1,800,000	Direct
Jun 5, 2026	ARCT Arcturus Therapeutics Holdings Inc.	Award(A) Stock option (right to buy)	15,000	-	-	Direct
Apr 1, 2026	RMD RESMED INC	Sale(S)	2,000	$225.00	$450,000	Direct
Mar 4, 2026	RMD RESMED INC	Sale(S)	2,000	$260.22	$520,440	Direct
Feb 4, 2026	RMD RESMED INC	Sale(S)	2,000	$251.31	$502,620	Direct
Jan 7, 2026	RMD RESMED INC	Sale(S)	2,000	$248.83	$497,660	Direct
Dec 3, 2025	RMD RESMED INC	Sale(S)	2,000	$251.47	$502,940	Direct
Nov 24, 2025	RMD RESMED INC	Award(A) ResMed Common Stock Options	1,331	$250.52	-	Direct
Nov 20, 2025	RMD RESMED INC	Award(A)	536	-	-	Direct
Nov 14, 2025	RMD RESMED INC	Exercise(M)	11,442	$101.64	$1,162,965	Direct
Nov 14, 2025	RMD RESMED INC	Tax Payment(F)	7,314	$244.46	$1,787,980	Direct
Nov 12, 2025	RMD RESMED INC	Sale(S)	2,000	$252.05	$504,100	Direct
Nov 11, 2025	RMD RESMED INC	Tax Payment(F)	163	$250.10	$40,755	Direct
Jul 2, 2025	RMD RESMED INC	Sale(S)	945	$255.49	$241,438	Direct
Jun 9, 2025	ARCT Arcturus Therapeutics Holdings Inc.	Award(A) Stock option (right to buy)	15,000	-	-	Direct
Jun 4, 2025	RMD RESMED INC	Sale(S)	2,000	$247.32	$494,640	Direct
May 7, 2025	RMD RESMED INC	Sale(S)	2,000	$242.25	$484,500	Direct
Apr 2, 2025	RMD RESMED INC	Sale(S)	2,000	$219.74	$439,480	Direct
Mar 5, 2025	RMD RESMED INC	Sale(S)	2,000	$227.71	$455,420	Direct
Feb 5, 2025	RMD RESMED INC	Sale(S)	2,000	$242.11	$484,220	Direct
Jan 2, 2025	RMD RESMED INC	Sale(S)	2,000	$230.99	$461,980	Direct
Dec 4, 2024	RMD RESMED INC	Sale(S)	2,000	$245.65	$491,300	Direct
Nov 25, 2024	RMD RESMED INC	Award(A) ResMed Common Stock Options	1,468	$249.56	-	Direct
Nov 20, 2024	RMD RESMED INC	Award(A)	542	-	$0	Direct

1-25 of 29 transactions

About FARRELL PETER C

FARRELL PETER C (SEC CIK 0001186102) files insider reports with the SEC as Director of RESMED INC (RMD) and Director of Arcturus Therapeutics Holdings Inc. (ARCT).

Signal8 holds 27 ownership filings by FARRELL PETER C, all Form 4s, filed between Sep 6, 2024 and Sep 4, 2026. Those filings report 29 transactions, from Sep 4, 2024 to Sep 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on FARRELL PETER C's filings is in SAN DIEGO, CA.

Recent filings by FARRELL PETER C

Sep 2, 2026: Open-market sale of RMD shares (Form 4, code S).
Aug 5, 2026: Open-market sale of RMD shares (Form 4, code S).
Jun 5, 2026: Grant or award of ARCT derivative securities (Form 4, code A).
Apr 1, 2026: Open-market sale of RMD shares (Form 4, code S).
Mar 4, 2026: Open-market sale of RMD shares (Form 4, code S).

Other insiders filing for RESMED INC (RMD)

Rider Michael J, Global General Counsel
Farrell Michael J., Chairman and CEO
Leong Justin, Chief Product Officer
Bloomer Aaron, Chief Financial Officer
Sandercock Brett, Chief Financial Officer
De Witte Jan, Director

How to read Form 4 transaction codes